Novartis And US Government Reach Agreement On Lowering Drug Prices In The US
I'm PortAI, I can summarize articles.
Novartis AG has reached an agreement with the US government to lower drug prices. The company plans to invest $23 billion in US research, development, and manufacturing, including a $1.1 billion research hub in San Diego and a manufacturing hub in North Carolina. Novartis expects three years of tariff relief and will make additional medicines available through direct-to-patient platforms by 2026, launching future medicines at comparable prices across high-income countries.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments